Welcome > Support > Âü°íÀÚ·á  
 
 
E
 
±Ûº¸±â
¼º¸í ÆijªÁø     (Date : 2016-07-13 10:15:49)
Á¦¸ñ [³í¹®] [2013]Detection of BRAF V600E mutation with thyroid tissue using pyrosequencing: comparison with PNA-clampingand real-time PCR.
³»¿ë

Am J Clin Pathol. 2013 Jun;139(6):759-64. doi: 10.1309/AJCPN3ULH6YWBHPH.

Detection of BRAF V600E mutation with thyroid tissue using pyrosequencing: comparison with PNA-clampingand real-time PCR.

Kang SH1Pyo JYYang SWHong SW.

Author information

1Department of Laboratory Medicine, Chosun University Medical School, Gwangju, Korea.

Abstract

We used pyrosequencing, peptide nucleic acid (PNA)-clamping polymerase chain reaction (PCR), and real-time PCR to detect the BRAF V600E mutation and to investigate the prognostic effect of the BRAF V600E mutation in paraffin block specimens from 100 patients diagnosed with papillary thyroid carcinoma. Positive rates of PNA-clamping PCR, real-time PCR, and pyrosequencing were 66%, 70%, and 68%, respectively. Pyrosequencing and PNA-clamping PCR detected mutant type in a 99:1 (wild-type: mutant) DNA concentration, and PNA-clamping PCR detected mutant type in a 99.5:0.5 DNA concentration. Clamping PCR showed higher κ value than real-time PCR (0.729 vs 0.626). The BRAF V600E mutation was associated with an advanced stage of cancer (P = .045) and was found to be associated with poor prognostic factors. This study suggests that pyrosequencing can be as sensitive as real-time PCR and that PNA-clamping PCR is a sensitive and reliable method to detect the BRAF V600E mutation.


 

 ¹øÈ£   Á¦¸ñ ÀÛ¼ºÀÚ ÆÄÀÏ Á¶È¸
   49           [³í¹®] [2016]Comparison of EGFR .. ÆijªÁø 28907
   48           [³í¹®] [2015]IDH Mutation Analys.. ÆijªÁø 65535
   47           [³í¹®] [2015]Low frequency of KR.. ÆijªÁø 29245
   46           [³í¹®] [2015]Simultaneous genoty.. ÆijªÁø 6103
   45           [³í¹®] [2014]Simultaneous diagno.. ÆijªÁø 21008
   44           [³í¹®] [2014]KRAS Mutation Detec.. ÆijªÁø 8158
   43           [³í¹®] [2013]Detection of EGFR m.. ÆijªÁø 1209
   42           [³í¹®] [2013]Detection and compa.. ÆijªÁø 5850
¢º           [³í¹®] [2013]Detection of BRAF V.. ÆijªÁø 6133
   40           [³í¹®] [2013]Comparison of Direc.. ÆijªÁø 25319
   39           [³í¹®] [Microarray]Peptide nucle.. ÆijªÁø 14357
   38           [³í¹®] [Clamp]Rapid and Sensitiv.. ÆijªÁø 22276
   37           [³í¹®] [ÆijªÁø Á¦Ç°»ç¿ë ³í¹®] EGFR µ¹¿¬º¯.. ÆijªÁø 3422
   36           [³í¹®] [ÆijªÁø Á¦Ç°»ç¿ë ³í¹®] Development .. ÆijªÁø 14192
   35           [³í¹®] [ÆijªÁø Á¦Ç°»ç¿ë ³í¹®] JHDM3A modul.. ÆijªÁø 1200
   34           [³í¹®] [PNA Chip vs DNA Chip ÀÓ»ó.. ÆijªÁø 4063
   33           [³í¹®] [ÆijªÁø ³í¹®¹ßÇ¥] PNA-mediated Re.. ÆijªÁø 8857
   32           [³í¹®] [ÆijªÁø Á¦Ç°»ç¿ë ³í¹®] ºñ¼Ò¼¼Æ÷Æó¾Ï¿¡.. ÆijªÁø 14511
   31           [³í¹®] [ÆijªÁø ³í¹® ¹ßÇ¥] PNA-Based Anti.. ÆijªÁø 1206
   30           [³í¹®] [ÆijªÁø ³í¹®¹ßÇ¥]Peptide nucleic .. ÆijªÁø 3926
 

< 1 2 3 >